ISCDx
Determining etiology of ischemic stroke (Cardioembolic vs. Large Artery Atherosclerosis)
CommercialActive
Key Facts
Indication
Determining etiology of ischemic stroke (Cardioembolic vs. Large Artery Atherosclerosis)
Phase
Commercial
Status
Active
Company
About Ischemia Care
Ischemia Care is a private, commercial-stage diagnostics company founded in 2017 and headquartered in San Francisco, CA. It has pioneered a blood-based RNA expression test (ISCDx) to determine the cause of ischemic stroke, addressing the significant clinical challenge of cryptogenic (unknown cause) strokes. The company's platform is supported by data from the large, prospective BASE clinical trial (NCT02014896), which enrolled 1,700 patients. Ischemia Care aims to integrate its testing into clinical workflows to enable precision secondary stroke prevention and reduce healthcare costs.
View full company profile